Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
NETTER-1 Phase III in Patients With Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate: Efficacy, Safety, QoL Results, and Subgroup Analysis Strosberg, J., Wolin, E., Chasen, B., Kulke, M., Bushnell, D., Caplin, M., Baum, R., Kunz, P., Hobday, T., Hendifar, A., Oberg, K., Sierra, M., Kwekkeboom, D., Ruszniewski, P., Krenning, E. LIPPINCOTT WILLIAMS & WILKINS. 2017: 440
View details for Web of Science ID 000394448600073